Analyst Ratings for Relmada Therapeutics Inc (RLMD)
RLMD Rating Summary
RLMD Price Target Summary
- Highest: $19.00 (Mizuho)
- Lowest: $8.00 (Leerink)
- Average: $12.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$12.40 (+95.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/24/2026 | Piper Sandler | Kelsey Goodwin | New Coverage | Overweight (N/A) |
12.00 (N/A) |
6.07 (6.33) |
4.28% | Details |
| 3/2/2026 | Lucid Capital Markets | Christopher Liu | New Coverage | Buy (N/A) |
14.00 (N/A) |
4.56 (6.33) |
38.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
